Influence of Age on Rates of New AIDS-defining Diseases and Survival in 6546 AIDS Patients

References

• Goedert J J, Kessler C M, Aledort L M, Biggar R J, Andes W A, White G C. A prospective study of human immunodeficiency virus type I infection and the development of AIDS in subjects with hemophilia. N Engl J Med 1989; 321: 1141–8
   PubMed Web of Science ®Google Scholar
• Rosenberg P S, Goedert J J, Biggar R J. Effect of age at seroconversion on the natural AIDS incubation distribution. AIDS 1994; 8: 803–10
   PubMed Web of Science ®Google Scholar
• Darby S C, Rizza C R, Doll R, Spooner R JD, Stratton I M, Thakrar B. Incidence of AIDS and excess of mortality associated with HIV in haemophiliacs in the United Kingdom: report on behalf of the directors of haemophilia centres in the United Kingdom. BMJ 1989; 298: 1064–8
   PubMedGoogle Scholar
• Sabin C, Phillips A, Elford J, Griffiths P, Janossay G, Lee C. The progression of HIV disease in a haemophiliac cohort followed for 12 years. Br J Haematcl 1993; 83: 330–3
   PubMed Web of Science ®Google Scholar
• Veugelers P J, Strathdee S A, Tindall B, Page K A, Moss A R, Schechter M T. Increasing age is associated with faster progression to neoplasms but not to opportunistic infections in HIV-infected homosexual men. AIDS 1994; 8: 1471–5
   PubMed Web of Science ®Google Scholar
• Biggar R J, International Registry ofSeroconverters. AIDS incubation in 1891 HIV seroconverters from different exposure groups. AIDS 1990; 4: 1059–66, andthe
   PubMed Web of Science ®Google Scholar
• Moss A R, Bachetti P, Osmond D, Krampf W, Chaisson R E, Stites D, Wilber J, Allain J-P, Carlson J. Seropositivity for HIV and the development of AIDS or AIDS related conditions: three year follow up of the San Francisco General Hospital cohort. BMJ 1988; 296: 745–50
   PubMed Web of Science ®Google Scholar
• Eyster M E, Gail M H, Ballard J O, Al-Mondhiri H, Goedert J J. Natural history of human immunodeficiency virus infections in hemophiliacs. Ann Intern Med 1987; 107: 1–6
   PubMed Web of Science ®Google Scholar
• Darby S C, Doli R, Thakrar B, Rizza C R, Cox D R. Time from infection with HIV to onset of AIDS in patients with haemophilia in the UK. Stat Med 1990; 9: 681–9
   PubMed Web of Science ®Google Scholar
• Mariotto A B, Mariotti S, Pezzotti P, Rezza G, Verdecchia A. Estimation of the acquired immunodeficiency syndrome incubation period in intravenous drug users: a comparison with male homosexuals. Am J Epidemiol 1992; 135: 428–37
   PubMed Web of Science ®Google Scholar
• Kopec-Schrader E, Tindall B, Learmont J, Wylie B, Kaldor J M. Development of AIDS in people with transfusion-acquired HIV-infection. AIDS 1993; 7: 1009–13
   PubMed Web of Science ®Google Scholar
• Hessol N A, Koblin B A, van Griensven G JP, Bacchetti P, Liu J Y, Stevens C E, Coutinho R A, Buchbinder S P, Katz M H. Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978–1991. Am J Epidemiol 1994; 139: 1077–87
   PubMed Web of Science ®Google Scholar
• Ferro S, Salit I E. HIV infection in patients over 55 years of age. J Acquir Immun Defic Syndr 1992; 5: 348–53
   PubMed Web of Science ®Google Scholar
• Rothenberg R, Woelfel M, Stoneburner R, Milberg J, Parker R, Truman B. Survival with the acquired immunodeficiency syndrome. N Engl J Med 1987; 317: 1297–02
   PubMed Web of Science ®Google Scholar
• Lemp G F, Payne S F, Neal D, Temelso T, Rutherford G W. Survival trends for patients with AIDS. JAMA 1990; 263: 402–6
   PubMed Web of Science ®Google Scholar
• Lundgren J D, Pedersen C, Clumeck N, Gatell J M, Johnson A M, Ledergeber B, Vella S, Phillips A, Nielsen J O, AIDS in Europe Study Group. Survival differences in European patients with AIDS. BMJ 1994; 308: 1068–73, andthe
   PubMed Web of Science ®Google Scholar
• Saah A J, Hoover D R, He Y, Kingsley L A, Phair J P, The Multicenter AIDS Cohort Study. Factors influencing survival after AIDS: Report from the multicenter AIDS cohort study (MACS). J Acquir Immune Defic Syndr 1994; 7: 287–95
   PubMed Web of Science ®Google Scholar
• Jacobsen M A, Bacchetti P, Kolokathis A, Chaisson R E, Szabo S, Polsky B. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine. BMJ 1991; 302: 73–8
   PubMedGoogle Scholar
• Payne S F, Lemp G F, Rutherford G W. Survival following diagnosis of Kaposi's sarcoma for AIDS patients in San Francisco. J Acquir Immun Defic Syndr 1990; 3(Suppl. 1)14–7
   Google Scholar
• Batalla J, Gatell J M, Caylà J A, Plasencia A, Jansà J M, Parellada N. Predictors of the survival of AIDS cases in Barcelona, Spain. AIDS 1989; 3: 355–9
   PubMed Web of Science ®Google Scholar
• Bindels P J, Poos R MJ, Jong J T, Mulder J W, Jager H JC, Coutinho R A. Trends in mortality among AIDS patients in Amsterdam, 1982–1988. AIDS 1991; 5: 853–8
   PubMed Web of Science ®Google Scholar
• Moore R D, Hidalgo J, Sugland B W, Chaisson R E. Zidovudine and the natural history of the acquired immunodeficiency syndrome. N Engl J Med 1991; 324: 1412–26
   PubMed Web of Science ®Google Scholar
• Friedland G H, Saltzman B, Vileno J, Freeman K, Schrager L K, Klein R S. Survival differences in patients with AIDS. J Acquir Immun Defic Syndr 1991; 4: 144–53
   PubMed Web of Science ®Google Scholar
• Pedersen C, Gerstoft J, Tauris P, Lundgren J D, Gøttzsche P C, Buhl M. Trends in survival of Danish AIDS patients from 1981 to 1989. AIDS 1990; 4: 1111–6
   PubMed Web of Science ®Google Scholar
• Bacchetti P, Osmond D, Chaisson R, Dritz S, Rutherford G W, Swig L, Moss A R. Survival patterns of the first 500 patients with AIDS in San Francisco. J Infect Dis 1988; 157: 1044–1047
   PubMed Web of Science ®Google Scholar
• Ohno-Machado L. Prognostic classification for AIDS patients in Brazil. J Med Syst 1993; 17: 163–72
   PubMedGoogle Scholar
• Eskild A, Magnus P, Nilsen Ø, Holme I. Survival of AIDS patients in Norway. Scand J Soc Med 1990; 18: 231–5
   PubMedGoogle Scholar
• Schinaia N, Bellocco R, Arcieri R, Zaccarelli M. Time from diagnosis of acquired immune deficiency syndrome (AIDS) to death among persons with blood-borne AIDS in Italy. Transfusion 1993; 33: 509–4
   PubMed Web of Science ®Google Scholar
• Therpenning M S, Bradley S F. Why aging leads to increased susceptibility to infection. Geriatrics 1991; 46: 77–80
   PubMed Web of Science ®Google Scholar
• Dix D, Cohen P, Flannery J. On the role of aging in cancer incidence. J Theor Biol 1980; 83: 163–73
   PubMed Web of Science ®Google Scholar
• Lebech M, Larsen S O, Petersen E. Prevalence, incidence and geographical distribution of Toxoplasma gondii antibodies in pregnant women in Denmark. Scand J Infect Dis 1993; 25: 751–6
   PubMed Web of Science ®Google Scholar
• Holmes F F, Wilson J, Blesch K S, Kaesberg P R, Miller R, Sprott R. Biology of cancer and aging. Cancer 1991; 68: 2525–6
   PubMed Web of Science ®Google Scholar
• Rabkin C S, Hatzakis A, Griffiths P D, Pillay D, Ragni M V, Hilgartner M W, Goedert J J, The National Cancer Institute Multicenter Hemophilia Cohort Study Group. Cytomegalo-virus infection and risk of AIDS in Human Immunodeficiency Virus-infected hemophilia patients. J Infect Dis 1993; 168: 1260–3
   PubMed Web of Science ®Google Scholar
• Wang F, So Y, Vittinghoff E, Malani H, Reingold A, Lewis E, Giordano J, Janssen R. Incidence proportion of and risk factors for AIDS patients diagnosed with HIV dementia, central nervous system toxoplasmosis, and cryptoccal meningitis. J Acquir Immune Defic Syndr 1995; 8: 75–82
   Web of Science ®Google Scholar